Excess hair growth or hair growth where hair is usually sparse.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
881 |
4. Check minimum number of eventsNone |
881 |
5. Include endpointsNone |
881 |
6. Filter based on genotype QC (FinnGen only) |
748 |
Control definitions (FinnGen only)
- Control exclude
- L12_DISORDSKINAPPENDIX
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- L68
- Name in latin
- Hirsutismus
Similar endpoints
↥List of similar endpoints to
Hirsutism in women
based on the number of shared cases.
Similar with more cases:
- Hypertrichosis
- Disorders of skin appendages
- Polycystic ovarian syndrome, consortium definition
- Diseases of the skin and subcutaneous tissue
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4246 | 4246 | - |
| Only index persons | 4165 | 4165 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.12 | - |
| Only index persons | 0.15 | 0.15 | - |
| Median age at first event (years) | |||
| Whole population | - | 30.89 | - |
| Only index persons | - | 30.87 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 748 | 748 | - |
| Unadjusted period prevalence (%) | 0.27 | 0.27 | - |
| Median age at first event (years) | 33.91 | 33.91 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 822
- Matched controls
- 8220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L68.0
ICD-10 Finland
Hirsutism
25135.2
307.7
796
10
C03DA01
ATC
spironolactone; oral
15.9
258.2
256
228
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
19.8
254.6
216
145
G03HB01
ATC
cyproterone and estrogen; oral
5.0
106.3
334
995
A10BA02
ATC
metformin; oral
5.1
105.4
314
895
E66.01
ICD-10 Finland
Obesity due to excess calories
3.9
61.6
229
737
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.8
48.6
175
544
L68.9
ICD-10 Finland
Hypertrichosis, unspecified
+∞
47.3
45
*
E66.8
ICD-10 Finland
Other obesity
4.3
46.8
135
357
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
5.6
44.7
90
176
A10BJ06
ATC
semaglutide; parenteral
5.6
42.0
84
163
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.3
41.8
194
705
T90
ICPC
Diabetes non-insulin dependent
3.4
41.8
179
619
103
Kela drug reimbursment
Diabetes, insulin-treated
3.3
41.8
195
711
G03DB01
ATC
dydrogesterone; oral
2.9
39.5
243
1034
E66.00
ICD-10 Finland
Metabolic syndrome
5.2
38.5
84
176
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
5.3
37.3
80
165
T82
ICPC
Obesity
4.3
34.6
97
249
7041A
ICD-9 Finland
Diseases of hair and hair follicles, Hirsutism[HIRSUTISMUS]
+∞
32.5
31
*
A10BK03
ATC
empagliflozin; oral
4.1
30.4
88
231
E66.9
ICD-10 Finland
Obesity, unspecified
4.3
30.2
82
205
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
29.4
466
2987
A10BH01
ATC
sitagliptin; oral
4.3
26.6
71
175
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.8
24.9
148
605
N05AH04
ATC
quetiapine; oral
2.4
24.3
224
1127
G03HA01
ATC
cyproterone; systemic
89.5
23.8
26
*
N97.0
ICD-10 Finland
Female infertility associated with anovulation
4.1
23.5
68
178
N05AX12
ATC
aripiprazole; systemic
3.4
23.2
88
277
L73.2
ICD-10 Finland
Hidradenitis suppurativa
20.2
22.3
33
17
L70.0
ICD-10 Finland
Acne vulgaris
4.2
21.2
59
150
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.0
20.7
60
157
L68.2
ICD-10 Finland
Localized hypertrichosis
215.2
20.7
21
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
20.0
193
980
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.8
19.9
62
171
A10BB12
ATC
glimepiride; oral
6.8
19.7
31
47
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.9
19.6
98
363
S10
ICPC
Boil/carbuncle
3.4
19.6
73
227
N06AX12
ATC
bupropion; oral
2.5
19.5
134
585
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.1
19.4
86
298
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.2
19.3
194
1001
N06AX16
ATC
venlafaxine; oral
2.2
18.9
189
972
N06AB04
ATC
citalopram; systemic
2.2
18.9
203
1075
G47.3
ICD-10 Finland
Sleep apnoea
2.3
18.0
168
838
A10BJ02
ATC
liraglutide; parenteral
4.7
17.9
42
93
C07AB07
ATC
bisoprolol; oral
2.0
17.9
260
1538
N05AX08
ATC
risperidone; systemic
3.1
17.7
77
263
N06AX11
ATC
mirtazapine; oral
1.9
17.5
320
2045
E66
ICD-10 Finland
Obesity
2.8
17.5
95
368
H01
ICPC
Ear pain/earache
2.2
17.4
173
885
N06AB03
ATC
fluoxetine; oral
2.4
17.3
138
644
H03AA01
ATC
levothyroxine sodium; systemic
2.0
16.6
238
1396
N05BA04
ATC
oxazepam; oral
2.0
16.4
250
1496
LCA06
NOMESCO Finland
Biopsy of endometrium
2.2
16.3
158
799
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
12.0
16.1
29
25
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
16.1
286
1800
N05BA06
ATC
lorazepam; systemic, sublingual
3.9
16.1
49
133
R42
ICD-10 Finland
Dizziness and giddiness
2.1
15.5
181
982
N06AB06
ATC
sertraline; oral
2.1
15.1
158
822
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.3
15.0
132
640
M79.6
ICD-10 Finland
Pain in limb
1.8
14.7
397
2823
N03AG01
ATC
valproic acid; systemic, rectal
2.9
14.6
72
264
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.4
14.6
54
167
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
14.4
100
436
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
14.3
134
666
N03AX09
ATC
lamotrigine; oral
2.7
14.3
84
338
L17
ICPC
Foot/toe symptom/complaint
1.8
14.2
275
1764
N06AB10
ATC
escitalopram; oral
1.8
14.1
262
1660
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
4.1
14.0
39
99
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.6
13.7
81
327
M54.5
ICD-10 Finland
Low back pain
1.8
13.7
356
2487
A11
ICPC
Chest pain NOS
3.0
13.7
62
217
N05CF01
ATC
zopiclone; oral
1.9
13.5
224
1365
N05AH03
ATC
olanzapine; systemic
2.6
13.4
82
337
N03AX12
ATC
[U] gabapentin; oral
2.2
13.3
128
643
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
6.0
13.1
23
39
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
13.1
132
675
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
13.0
137
711
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
13.0
140
733
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.0
384
2769
L03
ICPC
Low back symptom/complaint
1.8
12.8
296
1991
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
12.7
144
768
A10AE04
ATC
insulin glargine; parenteral
2.7
12.7
70
273
A02BC02
ATC
pantoprazole; systemic
1.7
12.6
511
4003
P76
ICPC
Depressive disorder
2.2
12.4
115
568
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.8
12.4
64
241
J01FF01
ATC
clindamycin; systemic
1.8
12.3
212
1302
E66.0
ICD-10 Finland
Obesity due to excess calories
14.6
12.3
20
14
P06
ICPC
Sleep disturbance
2.0
12.1
152
840
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
12.1
193
1156
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
12.1
75
310
A10BJ05
ATC
dulaglutide; parenteral
5.3
12.1
24
46
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
11.9
80
343
A28
ICPC
Limited function/disability NOS
2.5
11.7
75
315
QBJ30
NOMESCO Finland
Correction of abdominal apron
5.5
11.4
22
41
A10BK01
ATC
dapagliflozin; oral
3.0
11.4
50
172
OAB72, ,
SPAT
3.9
11.3
33
87
N05AA02
ATC
levomepromazine; systemic
3.5
11.2
39
116
C09CA01
ATC
losartan; oral
2.1
11.2
122
641
XLA10, ,
NOMESCO Finland
2.8
11.2
58
219
N03AX11
ATC
topiramate; oral
3.1
11.1
46
153
205
Kela drug reimbursment
Chronic hypertension
2.4
11.0
78
343
N03AX16
ATC
[U] pregabalin
1.9
11.0
163
952
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.5
11.0
37
108
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
10.9
57
216
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
10.9
132
720
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
9.8
10.8
21
22
A10BD07
ATC
metformin and sitagliptin; systemic
4.7
10.8
25
55
R53
ICD-10 Finland
Malaise and fatigue
1.7
10.8
251
1676
N02AX02
ATC
tramadol; systemic, rectal
1.7
10.7
286
1980
C10AA05
ATC
atorvastatin; oral
1.9
10.7
169
1006
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.6
179
1087
F61.0
ICD-10 Finland
Mixed personality disorders
3.9
10.6
31
82
D01
ICPC
Abdominal pain/cramps general
1.9
10.5
154
896
C07AA05
ATC
propranolol; systemic
1.7
10.5
218
1409
SPAT1262
SPAT
Handing over of treatment supplies
2.1
10.5
103
520
J02AC01
ATC
fluconazole; systemic
1.6
10.4
430
3315
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
10.4
88
418
N06AX21
ATC
duloxetine; oral
2.0
10.4
129
709
S18
ICPC
Laceration/cut
1.6
10.3
328
2370
R51.80
ICD-10 Finland
Headache
1.8
10.1
192
1206
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.1
10.1
43
145
P99
ICPC
Psychological disorders other
2.8
10.1
51
190
L68.8
ICD-10 Finland
Other hypertrichosis
40.6
10.0
12
*
A01
ICPC
Pain general/multiple sites
2.1
9.9
94
468
A10BH05
ATC
linagliptin; oral
4.8
9.8
22
47
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
9.8
314
2268
U04
ICPC
Incontinence urine
3.0
9.7
42
143
G44.2
ICD-10 Finland
Tension-type headache
1.8
9.6
160
965
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
9.6
176
1093
L73.9
ICD-10 Finland
Follicular disorder, unspecified
15.2
9.5
15
10
R06.0
ICD-10 Finland
Dyspnoea
1.7
9.5
190
1210
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
9.5
218
3096
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.6
9.5
224
3159
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.8
9.4
46
168
N03AE01
ATC
clonazepam; systemic
2.8
9.4
46
168
SPAT1310
SPAT
Counselling related to known health issue
1.6
9.4
281
1989
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
9.4
55
221
M04AA01
ATC
allopurinol; systemic
3.2
9.3
37
120
L15
ICPC
Knee symptom/complaint
1.7
9.3
205
1340
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
9.2
184
1170
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
9.2
80
384
N06AA09
ATC
amitriptyline; systemic
2.4
9.2
66
292
Z3231
NOMESCO Finland
Registered nurse
1.7
9.1
200
1305
L73.8
ICD-10 Finland
Other specified follicular disorders
11.6
9.1
16
14
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.1
9.0
88
442
SPAT1216
SPAT
Assessment of functional ability
2.2
9.0
81
394
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.2
9.0
35
112
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
9.0
158
969
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
8.9
169
1058
E0000UV, ,
ATC
1.6
8.9
365
2776
P01
ICPC
Feeling anxious/nervous/tense
1.7
8.9
220
1482
SPAT1240
SPAT
Therapeutic discussion
1.8
8.8
149
902
C09AA02
ATC
enalapril; systemic
2.2
8.8
75
357
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.9
8.8
123
702
R4110, ,
SPAT
2.0
8.6
101
544
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
8.5
108
596
M25.5
ICD-10 Finland
Pain in joint
1.6
8.5
308
2269
A08
ICPC
Swelling
2.8
8.5
41
149
E28.1
ICD-10 Finland
Ovarian dysfunction: Androgen excess
27.8
8.5
11
*
N05BA01
ATC
diazepam; systemic, rectal
2.0
8.5
93
488
P03
ICPC
Feeling depressed
1.7
8.4
161
1009
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
8.4
65
297
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
8.4
168
1066
ACC51
NOMESCO Finland
Release of median nerve
2.2
8.4
69
324
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.6
8.4
48
191
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.0
8.4
100
541
P29
ICPC
Psychological sympt/compl other
1.9
8.3
119
684
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.6
8.3
47
186
F61
ICD-10 Finland
Mixed and other personality disorders
14.6
8.2
13
9
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.9
8.2
116
664
H66.9
ICD-10 Finland
Otitis media, unspecified
2.0
8.2
93
495
OAB42, ,
SPAT
1.8
8.1
136
821
L60.0
ICD-10 Finland
Ingrowing nail
2.7
8.1
42
159
WX002
NOMESCO Finland
Sedation and analgesia
1.9
8.1
117
675
M79.1
ICD-10 Finland
Myalgia
1.7
8.1
166
1062
L72.1
ICD-10 Finland
Trichilemmal cyst
2.6
8.0
46
183
S76
ICPC
Skin infection other
2.6
8.0
46
184
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
7.9
64
298
M79.7
ICD-10 Finland
Fibromyalgia
2.5
7.9
49
203
L14
ICPC
Leg/thigh symptom/complaint
2.2
7.9
71
346
F40.1
ICD-10 Finland
Social phobias
2.6
7.9
44
173
S06
ICPC
Rash localized
2.5
7.9
47
191
G03DC02
ATC
norethisterone; oral
2.0
7.8
82
423
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
7.8
84
438
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.2
7.8
20
48
R06.5
ICD-10 Finland
Mouth breathing
2.2
7.7
62
288
L28
ICPC
Limited function/disability (L)
1.9
7.7
105
593
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.7
192
1289
L86
ICPC
Back syndrome with radiating pain
2.4
7.7
55
243
R4190
NOMESCO Finland
Nutritional therapy
2.6
7.7
44
175
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.7
167
1083
A10AB05
ATC
insulin aspart; parenteral
2.4
7.7
53
231
D06
ICPC
Abdominal pain localized other
1.9
7.7
103
580
SPAT1254
SPAT
Administration of medicine
1.8
7.6
118
694
N02BF02
ATC
pregabalin; oral
2.2
7.6
64
303
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.5
7.6
277
2034
C03CA01
ATC
furosemide; systemic
2.0
7.6
86
457
-34
ICPC
Blood test
3.0
7.6
32
108
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.6
173
1136
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.9
7.6
22
58
SPAT1260
SPAT
Consultation of another employee
1.8
7.6
135
829
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
7.5
37
136
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.9
7.5
103
584
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
7.5
173
1139
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.5
256
1852
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.5
7.5
18
41
N06AX26
ATC
vortioxetine; oral
1.9
7.4
98
548
A29
ICPC
General symptom/complaint other
1.9
7.4
98
548
N02BE01
ATC
paracetamol; systemic, rectal
1.8
7.4
718
6512
P72
ICPC
Schizophrenia
3.8
7.4
22
59
N04AA02
ATC
biperiden; systemic
3.8
7.4
22
59
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.5
7.4
75
1357
WX722
NOMESCO Finland
PEEP
3.7
7.3
23
64
L68
ICD-10 Finland
Hypertrichosis
+∞
7.3
7
*
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
7.3
478
3956
G03GB02
ATC
clomifene; oral
3.0
7.2
32
111
T83
ICPC
Overweight
2.7
7.2
38
145
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.2
7.1
57
265
N05CD07
ATC
temazepam; oral
2.4
7.1
48
207
A04
ICPC
Weakness/tiredness general
1.7
7.1
162
1062
N91.5
ICD-10 Finland
Oligomenorrhoea, unspecified
5.7
7.1
19
34
S29
ICPC
Skin symptom/complaint other
1.6
7.1
164
1079
R13
ICD-10 Finland
Dysphagia
2.4
7.0
49
215
J01AA02
ATC
doxycycline; systemic
1.5
7.0
574
4955
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.9
6.9
32
114
ZYC01, ,
SPAT
1.7
6.9
122
746
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
3.6
6.9
22
62
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
6.9
43
179
G04BD12
ATC
mirabegron; oral
2.2
6.9
57
269
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
6.9
139
883
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.8
6.8
34
126
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.6
6.8
132
1996
IHZ05, ,
SPAT
2.0
6.8
74
387
E28.0
ICD-10 Finland
Ovarian dysfunction: Estrogen excess
40.4
6.8
8
*
L29.9
ICD-10 Finland
Pruritus, unspecified
2.7
6.7
34
127
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.9
6.7
19
49
N05AB03
ATC
perphenazine; systemic, rectal
2.8
6.7
32
116
T07
ICPC
Weight gain
2.9
6.7
30
105
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
6.7
61
299
A46
ICD-10 Finland
Erysipelas
2.1
6.7
66
334
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
6.5
6.7
16
25
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.6
351
2765
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
6.0
6.6
17
29
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.6
98
569
N05BA12
ATC
alprazolam; oral
2.0
6.6
74
392
N06AX05
ATC
trazodone; oral
3.1
6.5
27
90
OAB50, ,
SPAT
2.2
6.5
51
235
W78
ICPC
Pregnancy
0.6
6.5
165
2345
J01DA09
ATC
[U] cefadroxil
1.5
6.5
216
1545
J01DB01
ATC
cefalexin; oral
1.6
6.5
684
6176
ZY010
NOMESCO Finland
Hospital outpatient
2.0
6.5
66
337
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.5
174
1185
QDH01
NOMESCO Finland
Excision of nail bed in toe
70.4
6.4
7
*
L64.8
ICD-10 Finland
Other androgenic alopecia
70.4
6.4
7
*
TQW99
NOMESCO Finland
Other minor procedure on skin
2.9
6.4
29
102
DHB50
NOMESCO Finland
Turbinoplasty
2.9
6.4
29
102
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
6.3
79
434
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
6.3
45
199
N06AB05
ATC
paroxetine; oral
2.2
6.3
54
258
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.4
6.3
22
66
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
3.9
6.3
18
47
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.9
6.3
18
47
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
6.3
186
1296
E27.0
ICD-10 Finland
Other adrenocortical overactivity
18.2
6.3
9
5
ULC02
NOMESCO Finland
Hysteroscopy
2.2
6.3
54
259
TLC02
NOMESCO Finland
Simple extraction of IUD
2.0
6.3
66
342
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.3
633
5630
G04CB01
ATC
finasteride; oral
26.9
6.2
8
*
F32
ICD-10 Finland
Depressive episode
2.0
6.2
70
371
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.6
6.2
112
1728
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.7
6.2
127
809
N05AH02
ATC
clozapine; systemic
3.3
6.2
22
67
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.1
379
3061
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
6.1
55
268
R03AC02
ATC
salbutamol; inhalant
1.4
6.1
480
4050
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.1
417
3429
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
6.1
296
2283
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
6.1
67
352
F33
ICD-10 Finland
Recurrent depressive disorder
2.4
6.1
42
183
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.2
6.1
53
255
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.5
6.1
37
152
C09CA06
ATC
candesartan; oral
1.6
6.1
164
1117
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
6.1
221
1609
N05CF02
ATC
zolpidem; oral
1.6
6.1
137
894
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
6.1
106
646
N05BE01
ATC
buspirone; oral
2.9
6.0
28
100
M10.9
ICD-10 Finland
Gout, unspecified
3.5
6.0
20
58
L05.0
ICD-10 Finland
Pilonidal cyst with abscess
5.6
6.0
16
29
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
6.0
104
632
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
335
146
38.04
307.65
1.8
1.3
1.51
1.65
nmol/l
0.30
306
135
264
76
50.70
307.65
1.5
1.1
7.13
6.56
umol/l
0.64
250
70
243
377
8.73
159.17
1.4
1.3
9.21
10.69
u/l
0.96
208
307
268
776
4.64
86.15
2.2
2.0
371.66
383.82
nmol/l
0.41
244
732
234
698
4.29
70.92
1.7
1.6
314.27
291.44
mu/l
0.83
227
620
117
211
6.30
63.78
2.0
1.5
437.65
369.25
mu/l
0.75
98
176
49
36
14.41
53.16
2.3
1.4
81.53
96.65
nmol/24h
0.46
49
36
249
952
3.32
50.24
1.5
1.4
12.53
21.76
iu/l
7.76
213
818
46
43
11.27
42.97
1.8
1.9
1.38
2.05
nmol/l
0.54
38
33
107
259
4.60
41.35
1.6
1.4
9.46
20.20
u/l
4.77
91
220
113
329
3.82
33.88
1.5
1.5
0.35
0.50
nmol/l
0.75
96
282
46
60
8.06
33.45
1.2
1.4
385.44
379.95
mu/l
0.03
46
60
46
62
7.80
32.53
1.2
1.4
71.91
76.60
%
1.25
46
62
50
82
6.43
29.57
2.8
1.7
39.63
20.43
ng/l
0.87
50
82
417
2598
2.23
27.66
2.3
1.8
98.43
97.99
pmol/l
0.06
238
1468
270
1410
2.36
27.34
4.8
4.1
9.13
9.42
mg/mmol
0.04
175
880
426
2758
2.13
24.69
6.3
5.3
1.22
1.22
mmol/l
0.55
374
2374
315
1828
2.17
24.13
3.9
3.3
8.21
7.90
mmol/l
0.46
275
1611
395
2503
2.11
24.03
3.8
4.1
36.75
37.28
g/l
1.32
369
2376
287
1608
2.21
24.00
1.8
1.5
20.67
20.34
nmol/l
0.16
258
1451
382
2410
2.09
23.30
5.4
4.9
1.22
1.22
mmol/l
0.16
354
2238
799
6917
6.54
22.97
15.0
10.1
139.52
139.53
mmol/l
0.07
789
6762
798
6936
6.16
22.03
15.2
10.2
3.92
3.89
mmol/l
3.73
787
6756
747
6227
3.19
21.94
7.3
4.4
38.97
36.63
mmol/mol
9.07
720
5987
639
4984
2.27
21.12
7.4
6.6
74.91
72.09
u/l
1.52
616
4748
224
1208
2.17
20.06
1.8
1.6
447.12
44268832.68
pmol/l
2.05
196
1073
766
6552
3.48
19.99
5.6
3.7
5.93
5.54
mmol/l
10.82
730
6214
753
6383
3.14
19.88
6.7
4.9
14.40
14.23
pmol/l
1.28
718
6043
654
5254
2.20
18.44
4.2
3.8
11.17
8.94
mm/h
4.92
618
4984
454
3227
1.91
18.06
4.8
5.1
8.54
9.54
umol/l
2.85
428
3057
505
3729
1.92
17.74
4.5
3.9
6.61
6.14
mmol/l
4.55
480
3339
154
750
2.30
17.47
1.7
1.6
1078.98
1161.11
nmol/l
0.60
124
573
314
2017
1.90
16.71
2.8
2.4
47.93
59.06
u/l
4.12
296
1882
795
7117
4.56
16.06
8.2
5.7
1.67
1.71
mu/l
0.51
773
6857
297
1918
1.86
15.23
2.6
2.5
27.88
18.70
ng/l
0.36
122
806
293
1921
1.82
14.07
2.4
2.1
2.61
2.48
mg/l
0.53
263
1675
451
3364
1.75
13.80
3.0
2.4
69.03
74.02
nmol/l
3.56
423
3186
317
2150
1.77
13.44
2.7
2.9
2.35
2.35
mmol/l
0.25
297
2012
267
1753
1.77
12.47
1.9
1.8
0.95
0.80
mg/l
0.22
197
1310
154
853
1.99
12.23
2.5
3.0
0.84
0.82
mmol/l
0.37
143
812
118
600
2.13
11.80
4.6
5.3
1.03
1.05
mmol/l
0.39
109
550
86
388
2.36
11.47
1.2
1.3
4.48
3.21
ug/l
2.09
80
366
229
1469
1.77
11.42
2.2
2.2
316.16
294.96
umol/l
2.95
202
1349
750
6720
2.33
10.97
12.5
9.2
96.35
95.20
ml/min/173m2
0.87
698
6012
178
1072
1.84
10.89
1.8
1.6
1.38
1.34
%
0.35
162
967
348
2527
1.65
10.88
3.5
2.9
27.06
26.40
u/l
0.25
328
2409
123
655
2.03
10.84
4.4
3.4
29.63
32.79
%
2.49
96
503
806
7520
4.69
10.34
17.2
11.8
66.14
65.28
umol/l
0.44
799
7438
162
964
1.85
10.25
2.0
2.7
397.13
490.99
ng/l
0.37
123
766
766
6962
2.47
10.20
5.6
4.1
2.80
2.83
mmol/l
0.63
729
6693
366
2740
1.61
9.82
1.9
1.8
1.55
1.29
mmol/l
5.64
316
2456
239
1617
1.67
9.58
2.3
2.0
242.84
159.15
u/l
0.27
229
1544
805
7541
4.26
9.48
12.5
9.1
27.53
23.19
u/l
13.05
791
7376
721
6438
1.98
9.46
4.3
3.3
1.42
1.16
mmol/l
15.79
683
6160
327
2400
1.60
9.43
1.4
1.3
1.41
1.85
u/ml
0.25
90
689
760
6924
2.29
9.36
5.1
3.8
4.60
4.77
mmol/l
6.27
734
6683
298
2158
1.60
8.99
3.3
2.9
—
—
—
0
0
151
918
1.79
8.81
1.2
1.3
119.15
173.62
u/ml
1.11
59
365
755
6909
2.14
8.39
5.1
3.8
1.34
1.54
mmol/l
38.88
722
6641
39
139
2.90
8.38
1.2
1.2
1.63
3652.24
iu/ml
0.51
12
35
158
992
1.73
8.22
2.2
2.2
15.04
14.71
umol/l
0.18
143
923
245
1724
1.60
8.19
1.3
1.3
12.73
26.33
iu/ml
3.64
51
508
145
903
1.74
7.73
2.2
2.2
2.52
2.47
g/l
0.45
125
829
113
662
1.82
7.41
3.2
3.5
4.58
4.62
pmol/l
0.20
97
604
782
7314
2.42
7.27
14.8
10.8
16.50
18.68
mg/l
1.63
681
5873
616
5384
1.58
7.23
4.0
2.9
35.55
30.17
u/l
2.80
594
5203
74
379
2.05
7.22
1.4
1.6
—
—
—
0
0
164
1080
1.65
7.06
2.3
2.2
2.43
2.41
mmol/l
1.87
143
963
96
1592
0.55
7.05
1.5
1.6
790.13
983.68
mu/l
1.52
75
1362
129
798
1.73
7.02
2.3
2.3
25.76
23.96
%
0.69
113
737
190
1314
1.58
6.66
2.3
2.5
104.89
90.30
ug/g
0.24
143
1023
270
2030
1.49
6.41
1.5
1.4
2.21
2.08
g/l
0.67
160
1344
10
7
14.44
6.41
1.0
1.0
16.37
11.31
pmol/l
—
10
7
188
1328
1.54
5.94
2.2
2.4
9.82
10.13
e6/l
0.06
174
1202
233
1726
1.49
5.87
3.1
2.6
0.24
0.36
e6/l
0.47
185
1205
34
137
2.55
5.85
1.3
3.6
1.02
0.92
nmol/l
0.31
27
116
486
4133
1.43
5.80
9.3
8.1
4.43
3.95
e9/l
5.65
434
3656
26
92
2.89
5.72
6.3
7.1
431.24
391.18
umol/l
0.25
21
82
263
2010
1.45
5.61
3.1
2.8
67.02
50.86
e6/l
0.21
213
1465
47
226
2.15
5.45
3.2
2.9
0.42
1.24
mmol/l
1.22
33
150
44
211
2.15
5.15
1.1
1.2
—
—
—
0
0
21
71
3.01
5.01
1.1
1.2
0.14
0.44
nmol/l
0.54
11
51
91
561
1.70
5.00
5.7
5.8
104.80
105.02
mmol/l
0.22
91
561
212
1586
1.45
4.97
1.3
1.3
3.07
10.40
u/ml
3.59
78
677
43
211
2.10
4.76
1.1
1.2
—
—
—
0
0
151
1064
1.51
4.76
2.5
2.2
7942.85
6411.92
u/l
0.16
41
467
67
384
1.81
4.74
4.1
3.9
83.74
69.85
ng/l
0.59
59
350
110
723
1.60
4.71
2.3
2.6
5.15
5.61
umol/l
0.19
84
610
14
30
4.73
4.69
2.1
2.0
1.46
1.41
nmol/l
0.05
14
23
63
360
1.81
4.51
1.8
1.6
8.41
8.96
u/ml
0.06
13
96
78
475
1.71
4.49
2.7
3.9
210.90
227.71
u/l
1.12
72
453
63
368
1.77
4.20
1.4
1.4
0.29
0.23
mg/l
0.27
18
141
28
122
2.34
4.14
1.3
1.3
—
—
—
0
0
42
755
0.53
3.95
1.5
1.6
—
—
—
0
0
131
935
1.48
3.86
2.9
2.6
222.26
299.46
ng/l
0.12
53
441
87
569
1.59
3.82
4.6
4.2
—
—
—
0
0
541
4855
1.33
3.71
4.0
3.3
73.65
58.98
ug/l
1.18
519
4641
33
162
2.08
3.70
7.8
3.9
1.86
1.61
%
0.57
33
156
9
16
5.67
3.66
2.2
2.2
—
—
—
0
0
92
621
1.54
3.53
1.1
1.0
—
—
—
0
0
21
459
0.44
3.52
1.2
1.3
—
—
—
0
0
137
1004
1.44
3.51
3.3
2.3
1.03
0.92
e6/l
0.20
82
465
67
420
1.65
3.50
3.1
2.7
1.22
1.23
mmol/l
0.35
56
355
84
559
1.56
3.44
1.7
1.7
—
—
—
0
0
92
627
1.53
3.39
2.3
2.4
31.88
34.59
u/l
0.34
73
519
57
900
0.61
3.35
1.5
1.6
49.47
59.07
ug/l
1.04
44
772
68
1029
0.63
3.33
1.4
1.4
—
—
—
0
0
59
365
1.66
3.26
1.6
1.8
—
—
—
0
0
66
423
1.61
3.18
1.5
1.4
—
—
—
0
0
34
608
0.54
3.17
1.4
1.5
47.86
60.55
ug/l
1.53
34
608
40
682
0.57
3.16
1.6
1.8
—
—
—
0
0
16
61
2.66
3.15
1.1
1.1
—
—
—
0
0
127
937
1.42
3.14
3.2
2.5
5.01
5.08
e6/l
0.03
72
405
37
205
1.84
2.99
1.1
1.2
—
—
—
0
0
18
75
2.43
2.98
1.8
2.2
141.08
97.79
ug/min
—
9
49
21
94
2.27
2.98
3.5
5.0
52.60
84.74
u/ml
—
7
31
24
116
2.10
2.85
2.6
1.9
7.94
6.21
pmol/l
0.48
24
116
66
435
1.56
2.85
9.1
6.8
0.75
0.59
mmol/l
0.16
52
352
25
124
2.05
2.78
1.8
1.6
—
—
—
0
0
48
296
1.66
2.72
1.4
1.6
—
—
—
0
0
110
813
1.41
2.70
1.8
1.8
—
—
—
0
0
11
35
3.17
2.65
1.0
1.4
145.73
156.96
mmol/24h
0.19
11
35
29
155
1.90
2.64
1.2
1.5
18.92
33.94
nmol/l
2.94
24
140
10
30
3.36
2.61
1.6
2.0
17.20
15.97
umol/l
—
10
30
17
74
2.32
2.59
1.0
1.3
—
—
—
0
0
8
20
4.03
2.57
1.3
1.6
—
—
—
0
0
55
822
0.65
2.56
1.4
1.5
—
—
—
0
0
56
833
0.65
2.55
1.4
1.5
0.94
1.17
ratio
1.71
33
517
56
833
0.65
2.55
1.4
1.5
1.04
0.94
ratio
0.80
33
515
37
217
1.74
2.52
9.4
7.8
17.20
15.98
%
2.84
37
208
56
831
0.65
2.52
1.4
1.5
0.91
1.14
ratio
1.58
33
513
17
75
2.29
2.52
1.0
1.3
—
—
—
0
0
17
75
2.29
2.52
1.0
1.3
—
—
—
0
0
8
21
3.84
2.46
1.0
1.2
—
—
—
0
0
17
76
2.26
2.45
1.0
1.3
—
—
—
0
0
17
76
2.26
2.45
1.0
1.3
—
—
—
0
0
17
77
2.23
2.39
1.0
1.3
—
—
—
0
0
8
22
3.66
2.37
4.0
3.3
0.50
0.73
index
—
8
22
262
2233
1.25
2.34
2.5
2.2
—
—
—
0
0
49
318
1.58
2.30
1.2
1.3
—
—
—
0
0
60
410
1.50
2.24
1.7
2.5
0.16
0.17
e6/l
0.04
54
389
214
1793
1.26
2.20
2.0
1.9
—
—
—
0
0
25
136
1.86
2.20
3.0
2.4
2.43
1.51
index
0.38
14
63
74
531
1.43
2.17
2.5
2.6
—
—
—
0
0
14
61
2.32
2.15
1.4
1.1
106.64
112.30
pmol/l
0.17
14
61
6
14
4.31
2.15
1.0
1.2
—
—
—
0
0
75
543
1.42
2.10
1.7
1.7
—
—
—
0
0
78
569
1.41
2.10
2.3
2.3
16.07
21.65
au/ml
—
8
74
9
31
2.92
2.07
1.9
1.9
—
—
—
0
0
280
2433
1.23
2.06
2.6
2.4
—
—
—
0
0
455
4156
1.21
2.01
4.2
3.4
0.00
4.72
estimate
1.08
104
908
456
4171
1.21
1.97
4.2
3.5
0.00
0.01
estimate
0.80
96
882
38
242
1.60
1.96
1.5
2.0
7.05
4.23
ug/l
0.36
28
215
41
266
1.57
1.96
1.5
1.5
0.22
0.29
iu/ml
—
5
36
191
1601
1.25
1.95
3.5
3.4
99.65
98.40
%
0.32
184
1556
450
4115
1.21
1.94
4.2
3.4
0.00
0.00
estimate
0.50
105
906
87
662
1.35
1.84
1.4
1.3
202.93
332.05
u/ml
0.36
80
621
12
53
2.28
1.81
2.4
1.8
—
—
—
0
0
25
146
1.73
1.79
1.0
1.1
118.20
116.98
%
0.08
20
133
54
381
1.45
1.77
2.2
4.1
23.73
20.84
ug/l
0.05
34
275
7
24
2.93
1.72
1.4
1.1
211.89
72.08
nmol/l
—
7
18
80
608
1.35
1.71
1.4
1.5
—
—
—
0
0
56
405
1.41
1.62
3.5
3.4
2.15
1.54
mmol/l
0.86
51
344
299
2671
1.19
1.58
1.9
1.8
—
—
—
0
0
60
445
1.38
1.52
1.5
1.7
3.95
3.58
mg/l
0.23
53
306
39
267
1.48
1.51
1.2
1.2
6.06
4.72
—
8
46
17
94
1.83
1.48
1.1
1.1
—
—
—
0
0
31
203
1.55
1.47
1.2
1.4
423.10
400.23
mg/l
0.15
31
194
42
296
1.44
1.42
1.5
1.3
48.64
120.94
pmol/l
1.20
42
287
15
82
1.84
1.36
1.1
1.2
—
—
—
0
0
349
3189
1.16
1.36
3.7
3.1
0.05
0.03
estimate
0.25
82
756
71
552
1.31
1.34
1.4
1.4
—
—
—
0
0
32
217
1.49
1.32
1.7
1.9
—
—
—
0
0
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
27
177
1.54
1.30
1.2
1.4
28.28
8.94
e6/l
0.53
18
137
29
194
1.51
1.28
1.5
1.4
291.17
338.56
ug/g
0.54
18
104
20
122
1.66
1.28
1.0
1.2
—
—
—
0
0
17
99
1.73
1.28
1.1
1.1
—
—
—
0
0
6
25
2.41
1.24
3.3
1.0
102.67
95.68
%
—
6
25
27
180
1.52
1.22
1.2
1.4
16.05
120.86
e6/l
1.61
21
145
5
19
2.64
1.21
1.0
1.3
6.68
5.47
mmol/l
—
5
19
25
164
1.54
1.21
1.0
1.1
—
—
—
0
0
35
247
1.44
1.21
1.8
1.6
—
—
—
0
0
45
333
1.37
1.19
1.7
1.6
—
—
—
0
0
14
79
1.79
1.17
1.8
1.4
—
—
—
0
0
42
310
1.37
1.14
1.7
2.3
2.54
4.28
iu/l
1.71
21
149
281
2560
1.15
1.10
1.7
1.6
—
—
—
0
0
68
543
1.28
1.09
1.6
1.6
—
—
—
0
0
7
33
2.13
1.05
1.1
1.2
11.91
12.56
pmol/l
—
7
28
11
60
1.84
1.03
1.3
1.6
4.51
6.09
ug/l
1.59
11
51
274
2502
1.14
1.03
3.1
2.8
0.01
0.08
estimate
0.54
85
760
28
198
1.43
0.99
1.8
1.8
—
—
—
0
0
7
36
1.95
0.97
2.9
1.7
103.00
106.25
mmol/l
—
7
36
9
152
0.59
0.89
1.1
1.4
—
—
—
0
0
39
298
1.32
0.89
1.1
1.1
6.22
5.48
eliau/ml
—
5
49
29
212
1.38
0.87
2.1
2.4
0.64
0.63
%
0.02
29
212
240
2197
1.13
0.86
4.3
3.4
0.00
0.00
estimate
1.08
99
881
31
232
1.35
0.82
1.8
2.9
3.80
3.54
g/l
0.44
31
220
6
32
1.88
0.82
2.7
3.6
—
—
—
0
0
14
89
1.58
0.81
1.1
1.2
13.70
12.81
u/ml
—
5
47
163
1461
1.14
0.81
2.2
1.9
—
—
—
0
0
23
164
1.41
0.80
1.2
1.3
1.43
3.90
u/ml
—
7
63
24
173
1.40
0.79
2.0
2.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
12
74
1.63
0.78
1.0
1.3
—
—
—
0
0
23
165
1.41
0.78
3.5
3.2
25.83
25.07
mmol/l
0.66
23
156
392
3708
1.11
0.78
2.9
2.7
—
—
estimate
—
0
0
42
333
1.28
0.76
1.9
2.4
3.51
4.55
umol/l
0.92
29
254
15
99
1.52
0.76
1.3
1.3
—
—
—
0
0
15
99
1.52
0.76
1.3
1.3
—
—
—
0
0
9
53
1.71
0.75
1.1
1.3
55.11
66.87
umol/l
—
9
53
23
167
1.39
0.74
1.2
1.3
1.33
4.32
u/ml
—
9
59
14
92
1.53
0.72
1.1
1.1
—
—
—
0
0
9
56
1.61
0.72
1.0
1.1
1533.22
1468.14
miu/ml
—
9
56
35
273
1.29
0.72
1.0
1.1
1.45
0.76
u/ml
0.21
13
112
29
220
1.33
0.72
1.3
1.3
—
—
—
0
0
26
194
1.35
0.72
1.0
1.1
25.94
16.09
au/ml
—
10
65
86
991
0.85
0.70
1.5
1.6
3.48
3.36
mmol/l
0.39
55
649
7
41
1.71
0.70
1.0
1.1
105.57
110.51
%
—
7
35
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
17
118
1.45
0.69
1.8
1.5
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
12.60
43.47
iu/ml
—
5
27
9
59
1.53
0.68
2.0
1.5
—
—
—
0
0
14
94
1.50
0.67
2.2
2.4
—
—
—
0
0
40
322
1.25
0.66
1.1
1.1
5.26
3.05
u/ml
0.31
23
162
7
44
1.60
0.65
1.7
1.6
—
—
—
0
0
5
30
1.67
0.61
1.0
1.1
—
3.38
u/ml
—
0
20
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
12
80
1.51
0.60
1.1
1.1
—
—
—
0
0
196
1812
1.11
0.59
3.7
3.3
1.02
2.70
kg/l
0.80
121
1199
21
157
1.35
0.59
1.3
1.4
120.00
158.49
au/ml
—
7
42
6
36
1.67
0.56
1.2
1.1
—
—
—
0
0
6
36
1.67
0.56
3.2
1.8
1.20
1.19
mmol/l
—
6
36
44
366
1.21
0.56
1.6
2.3
9.72
8.44
iu/ml
—
10
78
38
312
1.23
0.55
1.8
2.1
42.75
39.62
u/l
0.30
32
291
31
249
1.25
0.54
1.1
1.0
2.08
5.28
u/ml
1.34
15
118
6
39
1.54
0.53
1.3
2.6
1208.00
1600.33
mg
—
6
39
37
445
0.82
0.52
1.1
1.1
1.57
1.59
g/l
0.13
37
445
14
191
0.73
0.51
1.6
1.6
—
—
—
0
0
6
41
1.47
0.50
1.0
1.0
0.71
0.30
u/ml
—
6
41
35
289
1.22
0.49
1.0
1.1
4.78
3.96
u/ml
0.18
18
155
24
190
1.27
0.48
1.1
1.3
216.31
235.84
u/ml
0.18
13
127
191
1784
1.09
0.48
2.3
2.0
—
—
—
0
0
38
451
0.83
0.47
1.1
1.1
0.87
0.85
g/l
0.22
38
451
31
254
1.23
0.47
1.1
1.4
3.40
11.51
u/ml
—
5
48
116
1266
0.90
0.45
1.6
1.7
3.55
3.24
ratio
1.83
83
906
33
275
1.21
0.44
1.1
1.1
1.10
1.92
u/ml
0.71
19
132
5
33
1.52
0.41
1.0
2.1
68.20
84.00
nmol/l
—
5
33
17
132
1.29
0.40
1.1
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
5
36
1.39
0.38
1.4
1.4
—
—
—
0
0
7
53
1.32
0.31
1.1
10.1
10.36
6.39
mmol/l
—
7
41
36
409
0.87
0.30
2.3
2.0
—
—
—
0
0
27
232
1.17
0.29
1.0
1.1
3.00
6.11
u/ml
0.85
12
101
8
110
0.72
0.29
1.3
1.6
0.00
0.00
g/l
—
8
103
10
76
1.32
0.28
1.2
2.0
11.10
58.24
u/ml
—
10
76
64
586
1.10
0.27
1.2
1.4
224.21
242.82
miu/ml
0.16
34
308
13
161
0.80
0.27
1.1
1.4
—
—
—
0
0
8
65
1.23
0.27
6.3
4.1
25.25
64.82
u/ml
—
8
65
14
114
1.23
0.25
1.2
1.1
—
—
—
0
0
25
218
1.15
0.23
1.0
1.0
0.01
0.09
u/ml
—
6
63
43
390
1.11
0.23
1.2
1.4
—
—
—
0
0
5
39
1.28
0.23
6.4
1.6
—
—
—
0
0
5
39
1.28
0.23
1.2
1.1
105.02
161.62
iu/ml
—
5
39
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
2.5
—
2.04
—
0
13
648
6414
1.05
0.20
4.1
4.0
—
—
—
0
0
10
122
0.82
0.19
1.4
1.1
—
—
—
0
0
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
5
70
0.71
0.16
1.8
1.4
—
—
—
0
0
21
187
1.13
0.16
1.1
1.1
—
—
—
0
0
15
131
1.15
0.14
4.1
3.6
25.13
23.29
mg/l
—
8
89
12
103
1.17
0.13
1.0
1.3
—
—
—
0
0
8
98
0.81
0.13
1.3
1.2
—
—
—
0
0
50
472
1.06
0.13
2.8
2.4
102.04
82.28
ml/min/173m2
0.39
24
167
5
45
1.11
0.10
1.0
1.7
—
81.17
%
—
0
6
5
45
1.11
0.10
1.0
1.1
81.62
52.98
u/ml
—
5
45
10
113
0.88
0.08
1.7
1.6
—
—
—
0
0
5
64
0.78
0.08
1.0
1.4
—
—
—
0
0
11
123
0.89
0.08
1.1
1.4
—
—
—
0
0
7
67
1.05
0.08
1.3
1.3
—
—
—
0
0
7
67
1.05
0.08
1.3
1.3
—
—
—
0
0
7
68
1.03
0.08
1.3
1.3
—
—
—
0
0
6
70
0.86
0.07
1.0
1.4
—
—
—
0
0
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
10
112
0.89
0.07
1.2
2.2
—
—
—
0
0
7
84
0.83
0.07
1.3
1.2
—
—
—
0
0
7
85
0.82
0.07
1.0
1.4
—
—
—
0
0
10
90
1.11
0.05
2.2
1.6
0.55
0.48
e9/l
—
10
90
20
190
1.05
0.04
1.2
1.1
4.66
2.43
eliau/ml
0.53
11
100
15
142
1.06
0.02
1.5
4.4
—
144.00
iu/ml
—
0
14
17
162
1.05
0.02
1.2
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
1.20
—
0
9
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
3.30
—
0
6
0
6
0.00
0.00
0.0
1.3
—
7.68
—
0
6
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
349.80
—
0
5
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.3
1.1
13.17
7.27
mm/h
—
6
59
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
8861.20
—
0
5
0
5
0.00
0.00
0.0
1.0
—
0.00
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
76
0.92
-0.00
1.1
1.5
—
—
—
0
0
5
49
1.02
-0.00
1.6
2.4
530.60
531.00
e6/l
—
5
41
8
80
1.00
-0.00
1.3
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
26.13
—
0
8
8
87
0.92
-0.00
1.3
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
85
0.94
-0.00
1.3
1.1
—
—
—
0
0
8
86
0.93
-0.00
1.3
1.2
—
—
—
0
0
8
85
0.94
-0.00
1.5
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
49
1.02
-0.00
2.2
2.4
285.40
220.40
e6/l
—
5
43
Mortality – FinRegistry
↥Association
Association between endpoint L12_HIRSUTISM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_HIRSUTISM | 1.3 [1.05, 1.61] | 0.015 |
| Birth year | 0.998 [0.99, 1.01] | 0.583 |
During the follow-up period (1.1.1998 — 31.12.2019), 95 out of 3551 females with L12_HIRSUTISM died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have L12_HIRSUTISM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.129% | No data |
| 5 | 0.784% | No data |
| 10 | 2.05% | No data |
| 15 | 4.113% | No data |
| 20 | 7.223% | No data |
Relationships between endpoints
↥Index endpoint: L12_HIRSUTISM – Hirsutism in women
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data